Clinical Trial Update: Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers [Phase 3]

View source ↗

Summary

Phase 3 immunogenicity and safety study of a quadrivalent meningococcal conjugate vaccine administered with routine pediatric vaccines in healthy infants and to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Meningococcal Disease

Drugs mentioned

• MenQuadfi (Meningococcal quadrivalent conjugate vaccine)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Healthy Volunteers (Meningococcal Infection) | Phase 3 | Status: COMPLETED | Results posted: 2024-06-25